Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge

Vaccine

Volumn 25, Issue 10, 2007, Pages 1814-1823

  Hooper, Jay W ^a   Golden, Joseph W ^a   Ferro, Anthony M ^a   King, Alan D ^b  

^a UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^b Cyto Pulse Sciences   (United States)

Author keywords

DNA vaccine; Electroporation; Poxviruses

Indexed keywords

DNA VACCINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; LIVE VACCINE; NEUTRALIZING ANTIBODY; PLASMID DNA; SMALLPOX VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; GENE GUN; IMMUNIZATION; IMMUNOFLUORESCENCE TEST; LETHAL DOSE; MONKEYPOX VIRUS; MOUSE; NEEDLE; NONHUMAN; PRIMATE; PRIORITY JOURNAL; PROVOCATION TEST; SCAR FORMATION; SKIN; SMALLPOX; VACCINIA VIRUS; VIRUS GENE;

ANIMALS; ANTIBODIES, VIRAL; DISEASE MODELS, ANIMAL; ELECTROPORATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; MICE; MICE, INBRED BALB C; NEUTRALIZATION TESTS; PLASMIDS; SMALLPOX VACCINE; VACCINATION; VACCINES, DNA; VACCINIA; VACCINIA VIRUS;

EID: 33846593511     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.11.017     Document Type: Article

References (35)

1. Hooper J.W., et al. Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox. J Virol 78 (2004) 4433-4443
2. Lane J., and Goldstein J. Evaluation of 21st-century risks of smallpox vaccination and policy options. Ann Intern Med 138 (2005) 488-493
3. Edghill-Smith Y., Golding H., Manischewitz J., King L., Scott D., Bray M., et al. Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challenge. Nat Med 11 7 (2005) 740-747
4. Smith G.L., Vanderplasschen A., and Law M. The formation and function of extracellular enveloped vaccinia virus. Gen Virol 83 12 (2002) 2915-2931
5. Hooper J.W., Custer D.M., Schmaljohn C.S., and Schmaljohn A.L. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge. Virology 266 (2000) 329-339
6. Hooper J.W., Custer D.M., and Thompson E. Four-gene-combination DNA vaccine protects mice against a lethal vaccinia virus challenge and elicits appropriate antibody responses in nonhuman primates. Virology 306 (2003) 181-195
7. Galmiche M.C., Goenaga J., Wittek R., and Rindisbacher L. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens. Virology 254 (1999) 71-80
8. Donnelly J.J., Wahren B., and Liu M.A. DNA vaccines: progress and challenges. J Immunol 175 (2005) 633-639
9. Roy M.J., Wu M.S., Barr L.J., Fuller J.T., Tussey L.G., Speller S., et al. Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine. Vaccine 19 7-8 (2000) 764-768
10. Rottinghaus S.T., Poland G.A., Jacobson R.M., Barr L.J., and Roy M.J. Hepatitis B DNA vaccine induces protective antibody responses in human non-responders to conventional vaccination. Vaccine 21 31 (2003) 4604-4608
11. Roberts L.K., Barr L.J., Fuller D.H., McMahon C.W., Leese P.T., and Jones S. Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device. Vaccine 23 40 (2005) 4867-4878
12. Drape R.J., Macklin M.D., Barr L.J., Jones S., Haynes J.R., and Dean H.J. Epidermal DNA vaccine for influenza is immunogenic in humans. Vaccine 24 21 (2006) 4475-4481
13. Widera G., et al. Increased DNA vaccine delivery and immunogenicity by electroporation in vivo. J Immunol 164 (2000) 4635-4640
14. Babiuk S., et al. Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 20 (2002) 3399-3408
15. Hooper J.W., Custer D., Thompson E., and Schmaljohn C.S. DNA vaccination with the Hantaan virus M gene protects hamsters against three of four HFRS hantaviruses and elicits a high-titer neutralizing antibody response in rhesus monkeys. J Virol 75 (2001) 8469-8477
16. Delogu G., Li A., Repique C., Collins F., and Morris S. DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis. Infect Immun 70 1 (2002) 292-302
17. Ashok M., and Rangarajan P. Protective efficacy of a plasmid DNA encoding Japanese encephalitis virus envelope protein fused to tissue plasminogenactivator signal sequences: studies in a murine intracerebral virus challenge model. Vaccine 20 11-12 (2002) 1563-1570
18. Li Z., Howard A., Delogu G., Collins F., and Morris S. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. Infect Immun 67 9 (1999) 4780-4786
19. Feltquate D., Heaney S., Webster R., and Robinson H. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA Immunization. J Immunol 158 5 (1997) 2278-2284
20. Karupiah G., Buller M., Van Rooijen N., Duarte C., and Chen J. Different roles for CD4+ and DC8+ lymphocytes and macrophage subsets in the control of a generalized virus infection. J Virol 70 12 (1996) 8301-8309
21. Titomirov A.V., Sukharev S., and Kistanova E. In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. Biochim Biophys Acta 1088 (1991) 131-134
22. Dujardin N., Van Der Smissen P., and Preat V. Topical gene transfer into rat skin using electroporation. Pharm Res 18 (2001) 61-66
23. Babiuk S., et al. Needle-free topical electroporation improves gene expression from plasmids administered in porcine skin. Mol Ther 8 (2003) 992-998
24. Drabick J.J., Glasspool-Malone J., King A., and Malone R.W. Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization. Mol Ther 3 (2001) 249-255
25. Zhang L., Nolan E., Kreitschitz S., and Rabussay D.P. Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation. Biochim Biophys Acta 1572 (2002) 1-9
26. Zhang L., Widera G., and Rabussay D. Enhancement of the effectiveness of electroporation-augmented cutaneous DNA vaccination by a particulate adjuvant. Bioelectrochemistry 63 (2004) 369-373
27. Mikszta J.A., et al. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat Med 8 (2002) 415-419
28. Jones-Trower A., Garcia A., Meseda C.A., He Y., Weiss C., Kumar A., et al. Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin. Virology 343 (2005) 128-140
29. Pulford D.J., Gates A., Bridge S.H., Robinson J.H., and Ulaeto D. Differential efficacy of vaccinia virus envelope proteins administered by DNA immunisation in protection of BALB/c mice from a lethal intranasal poxvirus challenge. Vaccine 22 (2004) 3358-3366
30. Demkowicz W.E., Maa J.S., and Esteban M. Identification and characterization of vaccinia virus genes encoding proteins that are highly antigenic in animals and are immunodominant in vaccinated humans. J Virol 66 (1992) 386-398
31. Fogg C., et al. Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions. J Virol 78 (2004) 10230-10237
32. Davies D.H., McCausland M.M., Valdez C., Huynh D., Hernandez J.E., Mu Y., et al. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J Virol 79 18 (2005) 11724-11733
33. Snyder J.T., Belyakov I.M., Dzutsev A., Lemonnier F., and Berzofsky J.A. Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses. J Virol 78 13 (2004) 7052-7060
34. Lai C.F., Gong S.C., and Esteban M. The purified 14 kilodalton envelope protein of vaccinia virus produced in Escherichia coli induces virus immunity in animals. J Virol 65 (1991) 5631-5635
35. Fang M., Cheng H., Dai Z., Bu Z., and Sigal L.J. Immunization with a single extracellular enveloped virus protein produced in bacteria provides partial protection from a lethal orthopoxvirus infection in a natural host. Virology 345 (2006) 231-243